Drug Database
Back to search

Belgium· BE-AMP-SAM002791-00

Phenergan 50 mg/2 ml

A promethazine product containing promethazine hydrochloride, registered in Belgium by Sanofi Belgium. The same ATC class is registered in 14 of our 19 countries.

ATC R06AD02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedPhenergan 50 mg/2 mlATCR06AD02REGISTER NO.BE-AMP-SAM002791-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about promethazine hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Promethazine is registered in 14 of 19 countries.

Countries holding a registration under ATC R06AD02 (promethazine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search promethazine products by name

Promethazine · ATC R06AD02

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Promethazine Hydrochloride
Manufacturer
Sanofi Belgium
Country
Belgium (BE)
ATC code
R06AD02
ATC class
Promethazine
Defined daily dose
25 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    0125187
  • be_apb
    0714683

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

976 interactions on record for promethazine.

Graded by severity as the source publishes them — 87 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check promethazine against other medicinesHow interaction checks work

Promethazine · interactions on record

976 records

  • 87 severe
  • 625 moderate
  • 19 minor
  • 245 info

Most severe, free to view

  • MetoclopramideA03FA01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • Potassium chlorideA12BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Promethazine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All promethazine products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Bulgaria · Aнтиалeрзин
  • Cyprus · Promethazine Remedica
  • Czechia · Prothazin
  • Germany · Atosil, Atosil N
  • Denmark · Phenergan, Prometazin Actavis
  • Spain · Fenergan
  • France · Phenergan
  • United Kingdom (Northern Ireland) · Phenergan, Phenergan Elixir
  • Greece · Fenimezyl, Prugal-Derm
  • Hungary · Pipolphen
  • Ireland · Phenergan
  • Iceland · Phenergan, Prometazin Actavis
  • Italy · Alontan Antistaminico, Fadezin
  • Malta · Fenazil, Promethazine Remedica
  • Netherlands · Promethazine Ace, Promethazine Cf
  • Norway · Phenergan
  • Poland · Diphergan, Polfergan
  • Portugal · Prometazina Basi, Prometazina Medlink
  • Sweden · Farghess, Lergigan
  • Slovakia · Prothazin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/088774f9-dd81-4e31-b880-182b138fd4f2
GET /v1/drugs/088774f9-dd81-4e31-b880-182b138fd4f2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Phenergan 50 mg/2 ml",
  "name_fr": "Phenergan 50 mg/2 ml",
  "name_nl": "Phenergan 50 mg/2 ml",
  "amp_code": "SAM002791-00",
  "strengths": [
    "28.2000",
    "28.2000",
    "25.0000",
    "25.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Promethazine Hydrochloride",
    "Promethazine"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Promethazine",
  "authorisation_numbers": [
    "BE002791"
  ]
}
API referenceMCP serverPlans

See everything about promethazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console